STEVEN KROZER: Open Payments
NPI 1073060737 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$49,499 in 190 payments from 21 companies in 2025. Trend: 2023 $21,314 · 2024 $23,016 · 2025 $49,499
Speaker / faculty: $29,810Consulting: $8,672Travel & lodging: $6,493Food & beverage: $4,524
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 73 | $42,371 |
| ABBVIE INC. | 25 | $2,118 |
| Neurocrine BioSciences, Inc. | 9 | $1,819 |
| E.R. Squibb & Sons, L.L.C. | 6 | $1,108 |
| Alkermes, Inc. | 10 | $356 |
| Otsuka America Pharmaceutical, Inc. | 14 | $284 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $282 |
| LivaNova USA, Inc. | 1 | $198 |
| Axsome Therapeutics, Inc. | 6 | $197 |
| Almatica Pharma LLC | 6 | $102 |
Products named: SPRAVATO, VRAYLAR, REXULTI, CAPLYTA, ARISTADA, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, Auvelity, INGREZZA.
Industry payments across SC — which companies pay providers there.
